Citations

Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4784 total record number 156 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 43 out of 479
4784 citations found

A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses

Corbière, V;Lambert, EE;Rodesch, M;van Gaans-van den Brink, JAM;Misiak, A;Simonetti, E;Van Praet, A;Godefroid, A;Diavatopoulos, DA;van Els, CACM;Mascart, F;PERISCOPE WP5 Task 7 working group, ;

Product: Pertussis Toxin Mutant

  • Antigens for in vitro stimulation

    Pertussis toxin (PT) and filamentous hemagglutinin (FHA), the two Bp antigens present in all aP vaccines (36), were selected for in vitro stimulation of blood cells in the Bp-specific whole blood intracellular staining (BpWB-ICS) assay to expand vaccine-induced Bp-specific precursor T lymphocytes. A Bp lysate (BPL) was also used to detect cellular immune responses to Bp antigens that are not included in aP vaccines. A genetically detoxified PT mutant, with an inactivated S1 subunit (R9K, E129A), was chosen for the in vitro T cell assay (LIST Biological laboratories Inc., Campbell, CA, USA, #184) to avoid the toxic activity on target cells (37). …

    Product #184 – Pertussis Toxin Mutant

ertussis toxin-induced inhibition of Wnt/β-catenin signaling in dendritic cells promotes an autoimmune response in experimental autoimmune uveitis

Zhang, Z;Li, Y;Chen, N;Li, H;Chen, S;Cui, X;Shao, H;Wei, L;Ma, J;Zhang, S;Li, X;Zhang, X;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Adjuvant Injections Altered the Ileal and Fecal Microbiota Differently with Changes in Immunoglobulin Isotypes and Antimycobacterial Antibody Responses

Khadka, S;Omura, S;Sato, F;Tsunoda, I;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • 4.1. Animal Experiments

    We purchased six-week-old female C57BL/6 mice from CLEA Japan, Inc. (Tokyo, Japan). …

    We divided mice into two groups: the naïve and CFA-injected groups (eight mice per group). For the CFA-injected group, we sensitized mice subcutaneously with CFA that consisted of IFA (BD, Franklin Lakes, NJ, USA) and M. tuberculosis H37 Ra (BD) on days 0 and 19. The final concentration of M. tuberculosis in the CFA emulsions was 2 mg/mL (400 μg/mouse). We also injected CFA-injected mice with 300 ng of PT (List Biological Laboratories, Campbell, CA, USA) intraperitoneally on days 0 and 2. PT has been used by other research groups, including Johanson II et al. [25], for CFA-induced autoimmune models [64]. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

The activity of the aryl hydrocarbon receptor in T cells tunes the gut microenvironment to sustain autoimmunity and neuroinflammation

Merchak, AR;Cahill, HJ;Brown, LC;Brown, RM;Rivet-Noor, C;Beiter, RM;Slogar, ER;Olgun, DG;Gaultier, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Experimental autoimmune encephalomyelitis

    EAE was induced in both male and female mice between 8 and 12 weeks of age. MOG35-55 peptide (100 μg, CSBio; CS0681) was emulsified in complete Freund’s adjuvant containing Mycobacterium tuberculosis (1 mg/mL, Sigma; F5881; M. tuberculosis (BD 231141) added to final concentration of 4 mg/mL) and was injected subcutaneously (100 μL volume) at the base of the tail. Pertussis toxin (200 ng, List Biologicals; 180) was administered i.p. on the day of and 1 day after MOG immunization. …

    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Differential Effects of SARM1 Inhibition in Traumatic Glaucoma and EAE Optic Neuropathies

Liu, P;Chen, W;Jiang, H;Huang, H;Liu, L;Fang, F;Li, L;Feng, X;Liu, D;Dalal, R;Sun, Y;Jafar-Nejad, P;Ling, K;Rigo, F;Ye, J;Hu, Y;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • EAE induction and clinical scoring

    EAE/optic neuritis was induced with MOG (MOG33-55, GenScript, cat. no.163913-87-9) peptide and PTX (List Biological Laboratories, Campbell, CA, USA, cat. no. 181) in 9-week-old female mice with a procedure modified from the established protocol.29,30,44 Briefly, 225 μg MOG33-55 peptide emulsified with incomplete Freund’s adjuvant (IFA; BD Difco, 263910) and 2.5 mg/mL mycobacterium tuberculosis (BD Difco, 231141) were injected subcutaneously for immunization twice at days 0 and 7, and 500 ng PTX in PBS (2.5 μg/mL) was intraperitoneally injected twice at days 0 and 2 to break down the blood-brain barrier. Mice injected with the same volume of Freund’s adjuvant emulsion without MOG33-55 were used as sham controls. …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity

Rosichini, M;Bordoni, V;Silvestris, D;Mariotti, D;Matusali, G;Cardinale, A;Zambruno, G;Condorelli, A;Flamini, S;Genah, S;Catanoso, M;Del Nonno, F;Trezzi, M;Galletti, L;De Stefanis, C;Cicolani, N;Petrini, S;Quintarelli, C;Agrati, C;Locatelli, F;Velardi, E;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Generation of hTEC cultures

    Cell cultures of primary human TECs (hTECs) were established following the procedure originally described by Green et al33 with modifications. … To enrich for TECs, epithelial cell adhesion molecule (EpCAM)-positive cells were enriched by using anti-EpCAM (CD326) (clone HEA-125, Miltenyi, Bergisch Gladbach, Germany) staining and anti-APC microbeads (Miltenyi) separation. The TEC-enriched cell fraction was plated (2.5 × 104 cells/cm2) on a feeder layer of lethally irradiated 3T3-J2 murine fibroblasts (Kerafast, Boston, Mass) and cultured in a humidified atmosphere of 5% CO2 in growth medium composed of a mixture of Dulbecco modified Eagle medium and Ham’s F-12 (a 3:1 mixture), 10% FCS (ThermoFisher Scientific), insulin (5 μg/mL, Eli Lilly, Indianapolis, Ind), adenine (0.18 mM, Sigma, St Louis, Mo), hydrocortisone (0.4 μg/mL, Sigma), cholera toxin (0.1 nM, List Labs, Campbell, Calif), …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

A rapid multiplex real-time PCR detection of toxigenic Clostridioides difficile directly from fecal samples

Jia, XX;Wang, YY;Zhang, WZ;Li, WG;Bai, LL;Lu, JX;Ma, CF;Wu, Y;

Product: Anti-Clostridium difficile Toxin A (Chicken lgY)

  • Comparison with previously reported detection methods for tcdA and confirmation by ELISA for TcdA

    Two pairs of classic PCR primers for gene tcdA (Kato et al. 1999; Lemee et al. 2004) were compared with our method using 33 C. difficile RT017 isolates and 30 other types of clinical isolates preserved in our laboratory (Table S3). For inconsistent results, ELISA was employed for clarification. Briefly, negative control (ATCC43593), positive control (ATCC-BBA1803), and tested C. difficile (N20) isolates (Table S3) were anaerobically cultured in BHI liquid medium at 37 °C for 24 h. After centrifugation, the supernatant was taken and filtered through a 0.45 μm filter, then incubated overnight at 4 °C in a 96-well plate. The plate was washed with PBST(Phosphate Buffered Saline + Tween) and blocked with 5% bovine serum albumin at 37 °C for 2 h. Polyclonal antibody (List Biological Laboratories, Toxin A IgY, 1:1000 dilution) was used for the first hybridization, and horseradish peroxidase (HRP-conjugated goat anti-chicken IgY (Invitrogen, 1:5000 dilution) served as the secondary antibody. …

Tivantinib alleviates inflammatory diseases by directly targeting NLRP3

Huang, Y;Guo, Y;Zhou, Y;Huang, Q;Ru, Y;Luo, Y;Xu, W;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

CD8+ lymphocytes do not impact SIV reservoir establishment under ART

Statzu, M;Jin, W;Fray, EJ;Wong, AKH;Kumar, MR;Ferrer, E;Docken, SS;Pinkevych, M;McBrien, JB;Fennessey, CM;Keele, BF;Liang, S;Harper, JL;Mutascio, S;Franchitti, L;Wang, H;Cicetti, D;Bosinger, SE;Carnathan, DG;Vanderford, TH;Margolis, DM;Garcia-Martinez, JV;Chahroudi, A;Paiardini, M;Siliciano, J;Davenport, MP;Kulpa, DA;Siliciano, RS;Silvestri, G;

Product: Enterotoxin Type B from Staphylococcus aureus

  • Determination of intracellular cytokine induction following SIV-Gag peptide stimulation

    Staphylococcal enterotoxin A & B (SEB/A-List Biologicals stimulation at 250 ng ml−1 served as a positive control. Peptide diluent (1% dimethyl sulfoxide) served as the negative control. …

Gasdermin D pore-forming activity is redox-sensitive

Devant, P;Borši?, E;Ngwa, EM;Xiao, H;Chouchani, ET;Thiagarajah, JR;Hafner-Bratkovi?, I;Evavold, CL;Kagan, JC;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis